Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Foundayo™ (orforglipron) for adults with obesity, or overweight with weight-related medical problems. When used alongside a reduced- calorie diet and increased physical activity, Foundayo helps individuals lose excess body weight and keep the weight off. Foundayo will be available […] The post FDA approves Lilly’s Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions appeared first on Web-Release.

    Johnson & Johnson has announced a new initiative in the United Arab Emirates aimed at supporting access to liquid biopsy testing for patients diagnosed with metastatic non-small cell lung cancer (NSCLC). Through the program, the company will cover the cost of liquid biopsy testing for eligible patients where diagnostic testing may not be covered by […] The post Johnson & Johnson Launches Initiative to Support Access to Liquid Biopsy Testing for Non-Small Cell Lung Cancer in the UAE appeared first on Web-Release.